These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    Author: de Moor RA, Mourad L, ter Haar J, Egberts AC.
    Journal: Ned Tijdschr Geneeskd; 2003 Jul 12; 147(28):1370-2. PubMed ID: 12892015.
    Abstract:
    Withdrawal symptoms occurred in a male neonate after maternal use of venlafaxine for depression during pregnancy. The symptoms were restlessness, hypertonia, jitteriness, irritability and poor feeding. The diagnosis was confirmed by a temporary improvement after administration of a low dose (1 mg) of venlafaxine to the boy. Eventually the symptoms began to decline spontaneously, and ceased after 8 days. Exposure to venlafaxine and other antidepressants which inhibit serotonin reuptake during the third trimester of pregnancy carries the risk of a neonatal withdrawal syndrome.
    [Abstract] [Full Text] [Related] [New Search]